Company Monitoring Page for JNJ

latest headlines for company on cafepharma

The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
Medical Marketing and Media
Thu, 04/27/23 - 10:44 pm
Tags:
FTC, pharma marketing, deceptive marketing, JNJ, Pfizer
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Gilead Sceinces, JNJ, Merck, Pfizer, Regeneron, patents, activists
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
Tue, 04/25/23 - 10:44 am
Tags:
JNJ, consumer health, IPOs, Kenvue, spinoffs
J&J takes on Medtronic and Boston in pulsed field ablation
EP Vantage
Tue, 04/25/23 - 10:34 am
Tags:
JNJ, Medtech, pulsed field ablation, Medtronic, Boston Scientific, atrial fibrillation, Varipulse
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Benzinga
Tue, 04/25/23 - 10:28 am
Tags:
Genmab, JNJ, Janssen, Darzalex
J&J claims first approval for PARP combo Akeega
Pharmaphorum
Mon, 04/24/23 - 10:22 am
Tags:
JNJ, Janssen, Akeega, PARP inhibitors, metastatic castration-resistant prostate cancer, Europe
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen, Regeneron Pharmaceuticals, Sanofi, Supreme Court, patents, Pfizer, Bayer, Roche, Genentech, AstraZeneca, JNJ
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D, AbbVie, Amgen, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, GSK, JNJ, Merck, Merck KGaA, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, UCB, Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A, R&D, AbbVie, AstraZeneca, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
Tags:
CAR-T, Bristol Myers Squibb, JNJ, Legend Biotech, AACR, Multiple Myeloma, Carvykti, Abecma
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
Tue, 04/18/23 - 10:13 am
Tags:
JNJ, Janssen, earnings, restructuring, infectious disease
J&J opens the valve on $50M MS partnership with Pipeline
Fierce Biotech
Mon, 04/17/23 - 12:40 pm
Tags:
JNJ, Pipeline Therapeutics, MS, multiple sclerosis, PIPE-307
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News
Motley Fool
Fri, 04/14/23 - 09:55 am
Tags:
JNJ, legal
J&J opens its wallet with whopping $8.9B talc settlement offer
Fierce Pharma
Tue, 04/4/23 - 11:30 pm
Tags:
JNJ, legal
After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits
Fierce Pharma
Mon, 04/3/23 - 09:47 am
Tags:
JNJ, bankruptcy, legal
Could This Move by Johnson & Johnson Equal Billions for Moderna?
Motley Fool
Sun, 04/2/23 - 04:19 pm
Tags:
JNJ, Moderna Therapeutics, Pfizer, GSK, RSV, vaccines
Mathai Mammen, former J&J executive, to become FogPharma CEO
BioPharma Dive
Thu, 03/30/23 - 10:11 am
Tags:
JNJ, Pharma CEOs, FogPharma, cancer, startups, Mathai Mammen
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Wed, 03/29/23 - 03:56 pm
Tags:
Amgen, JNJ, Stelara, psoriasis, patents, biosimilars
J&J bows out of RSV vaccine race after scrapping trial
Yahoo/Reuters
Wed, 03/29/23 - 10:07 am
Tags:
JNJ, RSV, vaccines, clinical trials, Pfizer, GSK
Could This Drug Candidate Be a Winner for These 2 Big Pharma Stocks?
Motley Fool
Tue, 03/28/23 - 10:46 pm
Tags:
clinical trials, Bristol Myers Squibb, JNJ, milvexian, stroke

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.